The percentages of CD3−CD56+, CD56+CD16−, and CD56+CD16+ NK cells within the lymphocyte population were similar in aMCI and mild AD (mAD) patients compared to healthy individuals [94]. This evidence concerns the gene NCAM1 and Alzheimer disease.